- Report
- July 2024
- 100 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- July 2024
- 150 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- July 2024
- 150 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- January 2025
- 166 Pages
Global
From €4170EUR$4,650USD£3,576GBP
- Report
- March 2026
- 200 Pages
Saudi Arabia
From €2501EUR$2,789USD£2,145GBP
- Report
- July 2025
- 350 Pages
Global
From €4438EUR$4,949USD£3,806GBP
- Report
- July 2025
- 250 Pages
North America
From €3470EUR$3,869USD£2,975GBP
- Report
- July 2025
- 250 Pages
Europe
From €3470EUR$3,869USD£2,975GBP
- Report
- May 2023
- 140 Pages
Global
From €4438EUR$4,949USD£3,806GBP
- Report
- July 2024
- 100 Pages
Global
From €3363EUR$3,750USD£2,884GBP
- Report
- July 2024
- 115 Pages
Asia Pacific
From €4260EUR$4,750USD£3,653GBP
- Report
- July 2024
- 110 Pages
From €4260EUR$4,750USD£3,653GBP
- Report
- July 2024
- 120 Pages
Global
From €4260EUR$4,750USD£3,653GBP
- Report
- August 2022
- 96 Pages
Global
From €4479EUR$4,995USD£3,841GBP
- Report
- July 2025
- 250 Pages
Africa, Middle East
From €3470EUR$3,869USD£2,975GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3470EUR$3,869USD£2,975GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3470EUR$3,869USD£2,975GBP
- Report
- June 2026
- 118 Pages
Mexico
From €2689EUR$2,999USD£2,306GBP
€3586EUR$3,999USD£3,075GBP
- Report
- November 2024
- 159 Pages
Global
From €2242EUR$2,500USD£1,922GBP
- Report
- July 2024
- 166 Pages
Global
From €2242EUR$2,500USD£1,922GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more